Ajooni Biotech Share Price Today (AJOONI)
TODAY IN ONE LINE
AJOONI rose 2.0% on above-average volume (1.7x avg), outperforming Nifty's -0.4% move, supported by recent strong earnings.
With a market cap of ₹69.93 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Ajooni Biotech flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Reasonable ValuationTrading at a moderate P/E of 18.6x
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Earnings DeclineEPS (TTM) has contracted by 44.4% YoY
- ●Poor Capital ReturnsLow ROE of 4.8%
- ●Rising Receivables vs SalesReceivables grew 79.2% outpacing sales growth of 43.2%
Latest Ajooni Biotech News
What changed recently?
Recent events, corporate actions, and announcements.
Ajooni Biotech Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Ajooni Biotech Limited, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Ajooni Biotech Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Ajooni Biotech Limited — derived from the live tape, not yesterday's close.
Ajooni Biotech Limited last traded at ₹4.03 with an intraday range of ₹3.9–₹4.22 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹4.03| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 4.84 | +0.81 | +20.10% |
| R3 | 4.52 | +0.49 | +12.16% |
| R2 | 4.37 | +0.34 | +8.44% |
| R1 | 4.20 | +0.17 | +4.22% |
| PIVOT | 4.05 | 0.02 | 0.50% |
| CURRENT | 4.03 | — | — |
| S1 | 3.88 | -0.15 | -3.72% |
| S2 | 3.73 | -0.30 | -7.44% |
| S3 | 3.56 | -0.47 | -11.66% |
| S4 | 3.24 | -0.79 | -19.60% |
AJOONI is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: ₹3.9–₹4.22
Trading Inside opening range
Ajooni Biotech Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Ajooni Biotech Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Ajooni Biotech Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹69.93 Cr. and reported EPS of ₹0.25.
Ajooni Biotech segment analysis : revenue and profit mix.
Disclosed business segments at Ajooni Biotech with their share of revenue and profit, switchable between consolidated and standalone reporting.
Ajooni Biotech discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Ajooni Biotech Limited.
Our AI distills the core fundamental drivers supporting Ajooni Biotech Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Ajooni Biotech Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
TTM revenue growth 103.3% demonstrates strong market acceptance and demand momentum
Minimal debt-to-equity ratio 0.0019x provides substantial financial flexibility and stability
Stock trades at P/B 0.77, significantly below book value, suggesting potential undervaluation
Quarterly sales increased 107% YoY, reflecting positive market traction in recent periods
Conservative capital structure with equity ratio 75.8% ensures financial resilience
Key Risks.
Latest quarterly EPS declined 38.6% YoY despite revenue growth momentum
TTM EPS declined 44.4% YoY, signaling deteriorating profitability and earnings quality
Operating margin 2.53% TTM indicates razor-thin margins, highly vulnerable to cost pressures
ROCE 6.49% and ROE 4.82% reveal severely inefficient capital deployment and poor returns
Promoter holding decreased from 52.62% to 26.89%, signaling potential governance concern
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Ajooni Biotech Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Ajooni Biotech Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Ajooni Biotech Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Ajooni Biotech Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Ajooni Biotech Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Ajooni Biotech Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Ajooni Biotech Limited stood at 44.9% of traded volume, against a 20-day average of 67.9%.
Ajooni Biotech announcements: results, concalls, ratings, M&A.
Filings Ajooni Biotech sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Ajooni Biotech files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 60 documents below.
Updates
Ajooni Biotech Limited has informed the Exchange regarding 'Confirmation Certificate as per Regulation 74(5) of Securities and Exchange Board of…
Shareholders meeting
Ajooni Biotech Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 29, 2026
Updates
Ajooni Biotech Limited has informed the Exchange regarding 'Intimation of Book Closure for the purpose of Annual General Meeting'.
Amendment to AOA/MOA
Ajooni Biotech Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
Outcome of Board Meeting
Ajooni Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 29, 2026.
Ajooni Biotech dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Ajooni Biotech has declared, sequenced by announce and record date.
Ajooni Biotech corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Ajooni Biotech Limited: business, sector, key facts.
What Ajooni Biotech Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Ajooni Biotech Limited operates in the Animal Feed industry under the Fast Moving Consumer Goods sector, listed as NSE: AJOONI.
Ajooni Biotech Limited is an Indian company specializing in the manufacturing and sale of cattle feed. Established in 2010 and headquartered in Mohali, India, the company caters to the significant livestock feed market within the country. Their business model centers around providing a range of products designed to meet the nutritional needs of various animals.
The company's product portfolio demonstrates a commitment to diverse livestock feed requirements. They offer cattle feed chips as a core product, targeting the large cattle farming sector in India. Recognizing the importance of other livestock, they also produce camel feed, catering to a niche but vital part of the agricultural landscape. Furthermore, their product line includes cotton oil cakes and mustard oil cakes, which serve as cost-effective and nutritious supplementary feed components for various animals.
Beyond the primary feed products, Ajooni Biotech Limited also supplies feed supplements. These supplements are likely formulated to address specific nutritional deficiencies or enhance the overall health and productivity of the livestock. The inclusion of supplements demonstrates a focus on providing complete and balanced nutrition solutions, thereby enhancing the value proposition for their customers.
The overall business strategy appears to be centered on providing a comprehensive range of livestock feed products to meet the diverse needs of the Indian agricultural market. By offering both primary feed sources and essential supplements, Ajooni Biotech Limited aims to establish itself as a reliable and versatile supplier within the competitive Indian cattle feed industry. Their presence in Mohali provides a strategic location for distribution and access to key agricultural regions.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Amir Chand Jagdish Kumar (Exports) (AMIRCHAND) Share PricePeer
- B & A (BNALTD) Share PricePeer
- Bombay Super Hybrid Seeds (BSHSL) Share PricePeer
- Comfort Intech (COMFINTE) Share PricePeer
- Dangee Dums (DANGEE) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Ajooni Biotech Limited (AJOONI).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Ajooni Biotech Limited (AJOONI)?
The current share price of Ajooni Biotech Limited (AJOONI) is ₹4.03. Today, the stock has gained by ₹0.08 (2.03%), trading in a range of ₹3.9 to ₹4.22. The stock opened at ₹3.9 with a trading volume of 6,60,297 shares.
02What is the 52-week high and low price of Ajooni Biotech Limited stock?
The 52-week high price of Ajooni Biotech Limited (AJOONI) is ₹5.94, while the 52-week low is ₹3.4. Currently trading at ₹4.03, the stock is 24.8% away from its 52-week low and 32.2% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
03What is the dividend yield of Ajooni Biotech Limited and when is the next dividend?
Ajooni Biotech Limited offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹4.03, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
04How is Ajooni Biotech Limited stock performing today in the market?
Ajooni Biotech Limited stock opened at ₹3.9 and is currently trading at ₹4.03, showing a gain of ₹0.08 (2.03%). The intraday high is ₹4.22 and low is ₹3.9. The trading volume stands at 6,60,297 shares, indicating moderate market participation today.
05What is the market capitalization of Ajooni Biotech Limited?
Ajooni Biotech Limited has a market capitalization of ₹69.93 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹4.03) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
06What is the ROE and ROCE of Ajooni Biotech Limited?
Ajooni Biotech Limited has a Return on Equity (ROE) of 4.82% and Return on Capital Employed (ROCE) of 6.49%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
07Which sector and industry does Ajooni Biotech Limited belong to?
Ajooni Biotech Limited operates in the Fast Moving Consumer Goods sector and belongs to the Animal Feed industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
08What is the debt-to-equity ratio of Ajooni Biotech Limited?
Ajooni Biotech Limited has a debt-to-equity ratio of 0.19, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
The data, ratios and commentary about Ajooni Biotech Limited (AJOONI) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.